Gregory D Davis is Head of Research & Technology of SANGAMO THERAPEUTICS, INC. Currently has a direct ownership of 201,863 shares of SGMO, which is worth approximately $456,210. The most recent transaction as insider was on Nov 25, 2024, when has been sold 505 shares (Common Stock) at a price of $1.94 per share, resulting in proceeds of $979. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 202K
n/a 3M change
n/a 12M change
Total Value Held $456,210

Gregory D Davis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 25 2024
SELL
Payment of exercise price or tax liability
$979 $1.94 p/Share
505 Reduced 0.25%
201,863 Common Stock
Nov 24 2024
SELL
Payment of exercise price or tax liability
$1,355 $1.88 p/Share
721 Reduced 0.36%
202,368 Common Stock
GDD

Gregory D Davis

Head of Research & Technology
Richmond, CA

Track Institutional and Insider Activities on SGMO

Follow SANGAMO THERAPEUTICS, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGMO shares.

Notify only if

Insider Trading

Get notified when an Sangamo Therapeutics, Inc insider buys or sells SGMO shares.

Notify only if

News

Receive news related to SANGAMO THERAPEUTICS, INC

Track Activities on SGMO